Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Mallinckrodt
Cantor Fitzgerald
Daiichi Sankyo
Chinese Patent Office
Merck
Citi
Julphar

Generated: December 14, 2018

DrugPatentWatch Database Preview

Litigation Details for Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC (D. Del. 2011)

« Back to Dashboard

Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC (D. Del. 2011)

Docket ➤ Sign Up Date Filed 2011-08-18
Court District Court, D. Delaware Date Terminated 2013-11-22
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties CADENCE PHARMACEUTICALS INC.; EXELA HOLDINGS INC.; EXELA PHARMA SCIENCES LLC; EXELA PHARMSCI INC.; PADDOCK LABORATORIES INC.; PADDOCK LABORATORIES LLC; PERRIGO COMPANY; SCR PHARMATOP
Patents 6,028,222; 6,992,218
Attorneys Adam Wyatt Poff; Jack B. Blumenfeld; Richard L. Horwitz; Robert J. Katzenstein; Thomas C. Grimm
Link to Docket External link to docket
Small Molecule Drugs cited in Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-10-04 231 infringement of U.S. Patent Nos. 6,028,222 (the ’222 patent) and 6,992,218 (the ’21 8 patent) under 35 U.S.C…rights in the patents-in-suit. Plaintiff SCR Pharmatop, the patent owner, licensed the patents to BMS. BMS…sublicensed the patents to plaintiff Cadence but BMS retained substantial rights in the patents _ Th@r€f@r@… “ALL SUBSTANTIAL RIGHTS” IN THE PATENTS Standing to bring a patent suit is a question of subject matter… of the patent, such that the exclusive licensee holds “all substantial rights” in the patent. Alfr" External link to document
2012-10-24 249 8. The term “the Patents~in-Suit” means U.S. Patent No. 6,028,222 and U.S. Patent No. 6,992,218, collectively…Paddook”);_ WHEREAS, Plaintiffs suedPaddocl< for patent infringement based on Paddock’s filing of ANDA…concerning the use of any information set forth in the Patents- in-Suit during the development of the Paddock … 22 November 2013 1:11-cv-00733 830 Patent None District Court, D. Delaware External link to document
2012-11-09 268 and ‘218 patents Plaintiffs seek to obtain evidence relating to U.S. Patent Nos. 6,028,222 and 6,992,218… Defendants infringe the claims of U.S. Patent Nos. 6,028,222 and 6,992,218 based upon Case 1:11-CV-OO733…defenses offered are that the claims ofU.S. Patent Nos. 6,028,222 and 6,992,218 are invalid or would not be… and information pertinent to the issues in the patent litigation in the District Court for the District…Which the evidence is requested concerns a civil patent infringement lawsuit based upon a complaint filed External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
Dow
Healthtrust
Fuji
Federal Trade Commission
Fish and Richardson
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.